Adelman, A. E., Richardson, L., Jackson, L., Mathavan, A., Mathavan, A., Ataya, A., & Justice, J. (2026). Navigating Risk in Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia: Antithrombotic Versus Antifibrinolytic Therapy. Wiley. https://doi.org/10.1002/ohn.70187
Citazione stile Chigago Style (17a edizione)Adelman, Avraham E., Landon Richardson, Lindsey Jackson, Akshay Mathavan, Akash Mathavan, Ali Ataya, e Jeb Justice. Navigating Risk in Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia: Antithrombotic Versus Antifibrinolytic Therapy. Wiley, 2026. https://doi.org/10.1002/ohn.70187.
Citatione MLA (9a ed.)Adelman, Avraham E., et al. Navigating Risk in Atrial Fibrillation and Hereditary Hemorrhagic Telangiectasia: Antithrombotic Versus Antifibrinolytic Therapy. Wiley, 2026. https://doi.org/10.1002/ohn.70187.